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Abstract 
Background 
Children born with low gestational age (GA) or low birth weight (BW) are at increased risk of 
asthma. Twins as compared to singletons are on average more likely to be born with lower GA 
and BW, and have been hypothesized to comprise a high risk population for asthma. Many 
previous studies have not accounted for potential confounders or mediators. 
Objective 
To investigate the association between twinship and childhood asthma or early life wheeze and 
identify potential mediators, such as GA/BW.   
Methods 
The study population consisted of two cohorts including all children born in Sweden from 
January 1st 1993 to June 1st 2001 (n=756,363 singletons, n=22,478 twins) and July 1st 2005 to 
December 31st 2009 (n=456,239 singletons, n=12,872 twins). Asthma was defined using 
validated register-based outcomes of diagnosis or medication. The data were analysed using 
logistic (older cohort) and Cox regression (younger cohort). Adjusted models incorporated 
potential confounding or mediating factors including gestational age and birth weight.  
Results 
In the younger cohort, the crude hazard ratio (HR) of asthma medication after 1.5 years of age 
was 1.12 (95% CI 1.01-1.23), and fully adjusted HR 0.80, 95% CI 0.72-0.89. Crude HR of 
asthma diagnosis in the same age group was 1.14 (95% CI 0.99-1.30), fully adjusted 0.78 (0.68-
0.98). Adjusted analyses in the older group yielded similar results.  
Conclusions 
Twins were at significantly higher unadjusted risk of asthma or early life wheeze compared to 
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singletons in the younger, but not in the older cohort. Associations attenuated following 
adjustment for GA/BW suggesting that GA/BW mediates the effect of twinship on asthma risk. 
After adjustments twins were at lower risk of asthma outcomes, possibly due to unmeasured 
confounding.  
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Introduction 
Asthma is a worldwide contributor to childhood morbidity and the most frequent non-
communicable disease among children [1].  It is a disease of many phenotypes, and several 
longitudinal studies have attempted to describe the natural course of asthma-related symptoms 
throughout childhood [2-4].   Genetic, environmental and early life risk factors all contribute to 
the childhood asthma panorama [5-7]. The first environmental impressions that affect human 
health are made in utero; and several known risk factors for asthma are of intrauterine origin. 
Low birth weight [8-10] and shorter gestation [8-11] are associated with childhood asthma in 
twins [8, 9] as well as singletons [10, 11]. 
 
Twin studies can provide valuable insights on the relative contribution of genetic and 
environmental factors to disease development [12]. However, there could be concerns regarding 
generalisability to singletons from such studies. Twins share the limited intrauterine space with 
another person: their co-twin. Consequently, twins are smaller on average at birth compared to 
singletons and twin pregnancies are shorter [13]. This has led to the hypothesis that twins could 
be at higher risk of developing asthma compared to singletons, which would have implications 
for twin studies investigating asthma by suggesting that twins comprise a high-risk population, 
possibly with different underlying mechanisms for disease. Previous studies testing this have 
presented conflicting conclusions, some reporting a decreased risk of asthma in twins compared 
to singletons [10, 14-16] whereas others observe no significant differences [17-20]. These studies 
display important methodological differences particularly in terms of analytical methods. A 
central aspect of these differences is the selection of covariates, as many of the previous 
investigations have not adjusted their statistical models for potential confounding factors [18-20] 
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or have chosen not to include birth weight or gestational age in the models [17]. The selection of 
covariates becomes particularly important when aiming to distinguish between direct effects and 
those acting through known potential mediators, as failure to include a covariate implies that its 
role in the causal pathway cannot be assessed [21].   
 
The aim of our study is to estimate the association between twinship and asthma outcomes or 
early life wheeze in a large population-based birth cohort study based on Swedish health 
registers, while adjusting for mediating factors such as birth weight, gestational age and other 
perinatal factors. The study is carried out in one older and one younger group of children to 
illustrate possible differences related to age. 
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Methods 
Study design and data sources 
In Sweden, large population-based longitudinal birth cohort studies linking data from several 
different registers are made possible through the unique personal identification number [22].  In 
this study, several such registers were combined to connect birth characteristics and early life 
exposures to child health outcomes from hospitals and pharmacies.  The national registers 
included the Medical Birth Register (MBR, covering >97% of births in Sweden [23]), the 
Migration Register (up to December 31st, 2009), the Cause of Death Register (up to December 
31st, 2010), the longitudinal integration database for health insurance and labour market studies 
(LISA by Swedish acronym), the Multi-generation Register (MGR), the National Patient 
Register, NPR (up to December 31st, 2009) and the Prescribed Drug Register, PDR (started July 
1st, 2005; data available up to May 31st, 2011). The linkage between the population-based 
registers has been approved by the Regional Ethical Review board in Stockholm (Dnr 2013/862-
31/5) and did not require consent from participants. All data was anonymised and de-identified 
prior to analyses, and kept on a secure server. 
 
Study population 
The study participants were identified through the MBR and selected based on their birth dates. 
All live-born twin and singleton children were eligible for the study. Our study population 
consisted of two groups; the older cohort (born January 1st 1993 to June 1st 2001) and the 
younger cohort (born July 1st 2005 to December 31st, 2009). Birth date cutoffs in the older cohort 
were chosen to ensure that all study participants were covered for at least five years in the PDR 
before their 18th birthday.  Those who were deceased, had an emigration event not followed by a 
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return to Sweden before the start of the PDR or emigrated during follow-up were excluded from 
the older cohort. The younger cohort included all children born after the start of the PDR for 
whom information was available in the MBR. For both cohorts, the follow-up period took place 
between birth and December 31st, 2009 (for asthma diagnosis) and between July 1st 2005 (or 
birth for the younger cohort) and May 31st 2011 (for dispensed asthma medication).  
Between January 1993 and June 2001, 804,774 twin and singleton children were born in 
Sweden. Of these, 4,328 died during childhood and 21,605 emigrated without returning to 
Sweden before July 1st, 2005. This left n=778,841 individuals in the older cohort. From July 
2005 to December 2009, n=469,111 twin and singleton children were born into the younger 
cohort.  
 
Variables 
Information on twin or singleton status was collected from the MBR. This was also the source of 
information on gestational age, birth weight, child’s Apgar score at 5 minutes after delivery, 
mode of delivery, maternal smoking during pregnancy, involuntary childlessness and maternal 
body mass index (BMI). Maternal and paternal ages at the child’s birth were calculated based on 
parental birth dates retrieved from the MGR, which was also the source of information on the 
presence of older siblings sharing the same mother and of mother’s country of birth. The parents’ 
highest educational level was extracted from the LISA register. The highest attained level within 
each parent pair during the birth year of the child was used.  
Data on asthma outcomes were collected from the NPR (first asthma diagnosis in in- or 
outpatient care) and PDR (dispensed asthma medication). All diagnoses with an ICD-10 code 
J45 or J46 or ICD-9 code 493 were extracted from the NPR. For the older cohort, only diagnoses 
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given and medications prescribed between 5-18 years of age were included, indicating prevalent 
asthma. There was no age limit in the younger cohort, in contrast register coverage from birth 
allowed detection of incident asthma cases. Asthma medication use was assessed based on two 
pre-defined asthma medication outcomes, which have been validated against medical records 
with high positive predictive values for clinical asthma diagnosis [24], The first medication 
outcome was defined in the older cohort as >2 dispenses of inhaled corticosteroids, ICS (ATC 
code R03BA), fixed combinations of β2-adrenoreceptor agonists and ICS, β2-ICS (R03AK) 
and/or leukotriene receptor antagonists, LTRA (R03DC), independent of time between 
distributions. In the younger cohort, the same medications were used but time between dispenses 
had to be >14 days. For both cohorts, the second medication outcome was having >3 dispenses 
of, ICS, selective β2-adrenoreceptor agonists, β2 (ATC code R03AC), β2-ICS and/or LTRA 
within a year.  In both cohorts overall asthma medication was defined as fulfilling either the first 
or the second medication outcome. Additionally, combined outcomes were constructed. In the 
older cohort, the combined outcome was defined as either asthma diagnosis or medication, 
whereas in the younger cohort both a stricter requirement of both asthma diagnosis and 
medication was applied to reduce potential misclassification due to early life wheeze. 
Statistical methods 
In the older cohort logistic regression was used, estimating crude and adjusted odds ratios (ORs) 
with 95% confidence intervals (CI). In the younger cohort, which was followed from birth, time 
to event or censoring was calculated, and Cox proportional hazard regression performed, 
estimating crude and adjusted hazard ratios (HRs) with 95% CIs. Attained age was used as the 
time scale. Exit from the study population was through either asthma outcome (for medication 
outcomes, the date of the first prescription in combination with dispenses fulfilling the criteria) 
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or censoring at emigration, death, or end of follow-up (May 31st, 2011). Descriptive 
characteristics of all covariates were presented for twins and singletons and for the older and 
younger cohorts. Selection of confounders or mediators was based on potential association with 
both exposure and outcome. Only covariates which fulfilled these criteria, but which were not 
considered possible colliders or common consequences of exposure and outcome, were included 
in the adjusted models. For example, gender was not included in the adjusted models since it is 
not associated with twinship. In addition to the crude model, four adjusted models were 
constructed. Adjusted models 1 and 2 included only gestational age and birth weight, 
respectively. The fully adjusted model included gestational age and birth weight, as well as mode 
of delivery, Apgar score, highest parental education level at birth, and presence of older siblings. 
Adjusted model 3 was a reduced version of the fully adjusted model not including gestational 
age and birth weight. Directed acyclic graphs (DAGs) were used to support this process [25]. All 
standard errors were estimated using a sandwich estimator to account for the clustering of 
observations within families (twins and other siblings). The proportional-hazards assumption of 
the Cox proportional hazard regression was tested on the basis of Schoenfeld residuals in 
combination with visual inspection of hazard curves. If significantly non-proportional hazards 
for the twinship variable, age-dependent HRs were estimated and presented, with cut-offs based 
on the hazard curves. If the inclusion of a covariate was found to induce non-proportional 
hazards, the Cox regression model was stratified by said covariate. In both cohorts individuals 
with missing data on a covariate were excluded from adjusted analyses including said covariate 
(complete case analysis). Statistical analyses were conducted in STATA/IC 12.1 (StataCorp, 
TX).   
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Results 
Table 1 shows background characteristics of twins and singletons in the older and younger 
cohort. There was no difference in the proportion of males and females between twins and 
singletons in either cohort, but they displayed differences in distribution of all other variables. 
For example, 63.4 % of twins in the older cohort were born before 39 weeks of gestation, 
compared to 10.7% of the singletons, and twins in the older cohort were born with a birth weight 
lower than 2500 grams in 38.2% of births which was the case for only 3.0% of singletons. The 
same pattern was seen in the younger cohort. 
 
A selection of parental background characteristics are presented in Table 2.  Mothers of twins 
were slightly older compared to mothers of singletons. In the older cohort, 38.0% of mothers of 
twins were below 30 years of age, compared to 51.5% of the mothers of singletons. Smoking 
habits during pregnancy were similar between twin and singleton mothers.  Differences between 
twins and singletons for any given variable tended to follow the same pattern in both age groups. 
Parents of twins had consistently attained a higher educational level compared to parents of 
singletons.  
 
Results for the association between twinship and asthma outcomes in the older cohort are 
displayed in Table 3. In crude analyses, there was no significant difference between twins and 
singletons in terms of asthma diagnosis in the NPR (OR 1.04, 95% CI 0.98-1.11) or asthma 
medication (OR 1.04, 95% CI 0.99-1.10) between 5-18 years of age. When adjusting for 
gestational age, twins were at significantly lower odds of having any asthma diagnosis in the 
NPR (adjusted model 1, OR 0.83, 95% CI 0.78-0.88). This association was further emphasized 
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when also adjusting for birth weight, mode of delivery, Apgar score, parental education and 
presence of older siblings. In the model of all covariates except gestational age and birth weight, 
point estimates were similar as in the crude model but associations weaker. Similar findings were 
obtained for the asthma medication outcomes. Adjusting for birth weight yielded similar results 
as adjusting for gestational age for all asthma outcomes.  The combined definition of asthma 
(either diagnosis or medication) also resulted in similar estimates, crude OR 1.03 (95% CI 0.99-
1.09) and fully adjusted OR 0.83, 95 CI 0.79-0.87), not displayed in table. 
 
In the younger cohort, the proportional hazards assumption of the Cox regression models was not 
fulfilled. Hazard ratios are therefore estimated age-dependently. A summary of the results of the 
Cox regression analyses in the younger cohort is presented in Table 4. Between 0 and 1.5 years 
of age, the HR of receiving any asthma diagnosis in twins compared to singletons was 
significantly increased at 1.42 (95% CI 1.29-1.55) with similar HR for asthma medication 
outcomes. Similar to the older cohort, adjusting the analyses for gestational age reversed the 
direction of the associations, although a statistically significant reduced rate was only seen for 
asthma medication (HR 0.91, 95% CI 0.85-0.98). Models adjusted for birth weight resulted in 
that the association between twinship and asthma outcomes could no longer be detected. In the 
fully adjusted models, twins were at significantly lower risk of an asthma outcome compared to 
singletons.  After 1.5 years of age, twins were at significantly higher risk of asthma medication 
(HR 1.12, 95% CI 1.01-1.23), but not asthma diagnosis. Fully adjusted models consistently 
resulted in statistically significant reduced risk of twinship on asthma outcomes.  As in the older 
cohort, the model including all covariates except gestational age and birth weight yielded 
estimates in between crude and fully adjusted values. For asthma outcome defined as both 
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diagnosis and medication, crude HR between 0 and 1.5 years of age was 1.48 (95% CI 1.34-
1.63), whereas after 1.5 years of age it was 0.98 (95% CI 0.83-1.16). The fully adjusted HRs in 
the respective age groups were 0.85 (95% CI 0.76-0.94) and 0.68 (95% CI 0.57-0.81).   
 
Sensitivity analyses for all crude models including only individuals with gestational age >37 
weeks or birth weight between 2500-3500 grams resulted in similar results as the models 
adjusted for gestational age or birth weight, respectively (OR of asthma diagnosis between 5-18 
years was 0.92, 95% CI 0.86-0.99 in individuals with gestational age >37 weeks, compared to 
OR adjusted for gestational age in the same age group in the full cohort 0.83, 95% CI 0.78-0.99).  
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Discussion 
In this large population-based study, we found that twins were at increased risk of childhood 
asthma outcomes or early life wheeze compared to singletons in preschool ages, but not later in 
childhood. This finding was consistent across several definitions of asthma outcomes. We also 
saw that the distributions of gestational age and birth weight varied between twins and 
singletons. When gestational age was included in the statistical models, effect measures 
consistently showed significantly decreased risks of childhood asthma outcomes or early life 
wheeze in twins compared to singletons. Adjusting for birth weight had similar although slightly 
less pronounced effects. This indicates that the observed higher risk of childhood asthma in twins 
compared to singletons appears to be mediated by differences in gestational age and birth weight 
between these populations. 
 
The issue concerning whether gestational age [26] and birth weight [27] should be adjusted for in 
analyses of associations between early exposures and disease outcomes has been debated. The 
principal argument against including these factors in a statistical model is that significant 
unmeasured confounding may be introduced. This could occur if reasons for singletons to be 
born at a low gestational age are different from twins’, and that these reasons for prematurity are 
the real culprits resulting in observed lower risk of disease among twins. The notion that 
premature twins are better or at least not worse off than equally premature singletons in terms of 
neonatal outcomes is supported to some degree by the literature. Twins have been reported to be 
less severely affected by gestational hypertension [28] and diabetes [29]. Comparing twins and 
singletons with very low birth weight [30] or matched for growth restriction [31], previous 
studies could not show significant differences in terms of certain neonatal outcomes (including 
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sepsis and intraventricular haemorrhage). Twins and singletons matched for gestational age also 
did not display differences in incidence of adverse neonatal outcomes including respiratory 
distress syndrome, intraventricular haemorrhage [32, 33], sepsis, pneumothorax [33], and 
neonatal mortality [32, 34]. However, it remains possible that relevant differences exist. While 
the identity of these potential unmeasured confounders remains unknown, we argue that 
adjusting our analyses for gestational age and birth weight adds a new layer of information, 
although the results should not be used to infer a causal effect of twinship in itself.  This implies 
that differences in prevalence between twins and singletons do not preclude generalisability from 
twin studies, but rather that the biological mechanisms relevant to the exposure-outcome 
association under study should be considered in each case [35]. 
 
Previous studies of twinship as a risk factor for asthma have come to diverging conclusions [10, 
14-20]. Our study is the first to show an increased risk of asthma outcomes or early life wheeze 
in twins, and one of few to include gestational age and birth weight as covariates. Among the 
four previous studies which did not report significant difference in asthma risk between twins 
(sometimes including triplets and higher order multiples) and singletons [17-20], one (Huovinen 
and Kaprio) studied self-reported asthma in adults [19] and three (Huovinen and Kaprio, 
Davidson et al and Sicignano et al) presented only unadjusted statistical models [18-20]. Aspberg 
et al included a multivariate model, but did not adjust for birth weight or gestational age [17]. 
Two previous British studies showed a decreased risk of asthma in twins in unadjusted models 
[15, 16], although McKeever et al mentioned that adjusting for some potential confounders other 
than birth weight or gestational age did not significantly alter the effect estimates [16]. One 
previous literature review available on the subject [36] was based on papers studying the 
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prevalence of asthma in twins alone and does not contain direct comparisons between twin and 
singleton individuals in the same setting. Finally, two previous studies (Dik et al 2004 and 
Bråbäck and Hedberg 1998) showed a decreased risk of asthma in multiple birth individuals, 
adjusted for birth weight and gestational age [10, 14], which is in agreement with our adjusted 
findings. However, neither of these studies were carried out specifically in twins but also 
included other multiple birth individuals such as triplets, and one did not include children [14].    
 
Ideally, comparisons between previous studies should be made based on both crude and adjusted 
estimates with relevant covariates. Different definitions of outcome between studies may pose 
additional problems in terms of comparisons. Whereas we applied a set of validated register-
based outcomes from registers reflecting both in- and outpatient as well as general practice care 
in Sweden, previous studies used either self-reported diagnoses or symptoms [14, 19], diagnoses 
given only in connection with a hospital admission [15, 17, 18] or included those given also at 
other types of clinical visits [10, 16]. For these differences in definition of asthma to act in 
different directions between studies requires a process in which asthma is over- or 
underestimated in twins compared to singletons. This could be the case if an asthma diagnosis in 
one twin leads to the co-twin also being examined in some health care systems, but not in others, 
or if twins are more likely to self-report asthma if their co-twin also has the disease.  Another 
possible mechanism could lie in a higher degree of health care consumption during childhood in 
twins compared to singletons due to other factors, which could lead to that milder cases of 
asthma would be discovered to a higher extent in twins. As hospital admission due to asthma is 
associated with more severe cases of the disease, however, the previous potential explanations 
should mainly be applicable when using outcomes typically related to less severe disease. 
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Strengths of our study are several. Firstly, we studied a large population with robust measures of 
exposure and validated register-based outcomes [24].  Secondly, we adjusted for confounders not 
included in previous studies, which enabled us to estimate direct effects, accounting for 
mediation by gestational age and birth weight as well as other potentially relevant factors. 
Thirdly, the possibility to study different age groups indicated that the associations shown are 
particularly pronounced on incident disease in early childhood. The study should also be 
interpreted in the context of its limitations. In general, coverage of the Swedish registers is high, 
however, the outpatient part of NPR is an exception with 80% coverage since 2001 [37]. As 
there is no reason to believe register coverage is different between twins and singletons, this 
should not lead to differential misclassification. Finally, an important concern in the younger 
cohort is that asthma is not the only condition featuring wheeze, and as a result the register-based 
outcomes are less specific in this age group, potentially also including children with infection-
induced symptoms [38] . Based on the previous validation study of the PDR and NPR, about 1/4 
of the cases classified as asthma before 4.5 years of age may have obstructive bronchitis or other 
respiratory symptoms [24]. However, we do not expect this issue to be more or less common 
among twins compared to singletons.  The validity of the register-based outcomes for preschool 
children is improved when combining PDR and NPR data; when using both data sources 89% 
fulfilled criteria for asthma [24]. When we thus constringed the asthma definition in our 
analyses, we found that the patterns observed when studying the two outcomes separately 
remained.  
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In conclusion, we observed an increased risk of childhood asthma outcomes or early life wheeze 
in twins compared to singletons in preschool ages, which was largely consistent across asthma 
outcomes. The association between twinship and asthma appeared to be mediated by gestational 
age and birth weight; adjusting for these factors throughout childhood resulted in a significantly 
decreased risk of childhood asthma in twins, which may be due to unmeasured confounding. 
Further research on the nature of childhood asthma in twins compared to singletons could shed 
more light on this issue by highlighting the underlying biological mechanisms. 
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